Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop medicines designed to address some of the unsolved problems in aging. Its PureStem derived cell-based therapeutic candidates in development are AGEX-VASC1, AGEX-BAT1 and AGEX-iTR1547.
| Last: | $2.505 |
|---|---|
| Change Percent: | 95.7% |
| Open: | $2.1 |
| Close: | $1.28 |
| High: | $2.68 |
| Low: | $2.02 |
| Volume: | 110,767,000 |
| Last Trade Date Time: | 03/19/2026 12:48:14 pm |
| Market Cap: | $22,649,684 |
|---|---|
| Float: | 7,301,827 |
| Insiders Ownership: | 2.9% |
| Institutions: | 11 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.serinatx.com |
| Country: | US |
| City: | Huntsville |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Serina Therapeutics Inc. (NYSE: SER).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
